What did investors in the growth-leveraged momo-darling stocks, that have raced back to record highs and "proved" that all is well in the world again, see in the Non-farm payrolls report that scared them short? From the peak last week, momo growth names have been monkey-hammered and even M&A-driven Biotech exuberance has given up over 7%...
[3]
